Perspectives: Plans From Trump, Pelosi to Curb High Drug Costs Will Halt Innovation, Create Disruptions We Can’t Afford
Read recent commentaries about drug-cost issues.
Archives: Morning Breakouts
23,401-23,420 of 113,152 results
-
-
A Researcher’s Heretic Question: Is Washington’s Obsession With Rare Diseases The Best Use Of Taxpayer Dollars?
Read about the biggest pharmaceutical development and pricing stories from the past week in KHN's Prescription Drug Watch roundup.
By brilabuskes -
Viewpoints: U.S. Food System Isn’t Safe And FDA’s Aversion To Regulating Isn’t Helping; Protect Teens From Nicotine Addiction By Banning Flavored E-Cigs For Starters
Editorial pages focus on these health issues and others.
By janicelkff -
State Highlights: Health Officials Will Scour Communities Near Louisiana Plant For Cancer Cases; Missouri Revamps System For Reporting Elder Abuse After Severe Flaws Found
Media outlets report on news from Louisiana, Missouri, New Jersey, Wisconsin, Iowa, New Hampshire, California, Georgia, and Massachusetts.
By brilabuskes -
Former Outcome Health Executives Face Charges Of Allegedly Falsifying Data In $1B Fraud Scheme
The case was sparked by reports that the company—which displays pharmaceutical ads in doctors’ offices—had misled some customers with inflated data and fake reports.
By brilabuskes -
University Backtracks On Decision Not To Let Students Use Medicaid After Being Thrust In National Spotlight
Reports that Brigham Young University-Idaho wouldn't accept Medicaid as acceptable insurance for students prompted an outcry of criticism. The university had claimed the change was due to the impracticality for the local medical community to provide for the health care needs for the students, but local providers disputed that reasoning.
By brilabuskes -
CMS Spent Millions On Tool To Help Medicare Beneficiaries, But It’s Giving Seniors Wrong Info On Plans
CMS revamped its system to help beneficiaries navigate Medicare enrollment, but the newly redesigned tool has been causing confusion for many instead. The flawed results being shown include inaccurate premium estimates, incorrect prescription drug costs and inaccurate costs with extra help subsidies.
By brilabuskes -
Lawmakers Optimistic About Breaking Stalemate On Stalled Surprise Billing Negotiations
While many in Congress are agreed that something must be done to address surprise medical bills, the lawmakers have been split over which of a handful of strategies to choose in moving forward. In other health industry and insurance news: record-high debt, gender pay gaps, state health exchanges, and more.
By brilabuskes -
‘Trying To Reduce Anxiety’: Instagram Explores Ways To Take Away Likes, Improve Mental Health
By removing users ability to see how many likes their followers got but allowing them to see likes on their own posts, might make social media less stressful. But marketing agencies say the change would not be beneficial for businesses looking to market through high-profile users. Other news on mental health comes from California, Connecticut, Wisconsin and Illinois.
By brilabuskes -
Behind The Thousands Of Lawsuits Against Roundup Weed Killer Lurks A Sophisticated, Little-Known Legal Ecosystem
The Wall Street Journal lifts the curtain on the behind-the-scenes work to build a public health legal challenge against a big company. In other public health news: football and CTE, caregivers, bias in science, dementia fears, screen time for toddlers, foster care, and more.
By brilabuskes -
Busting Myths: Don’t Wash Your Turkey Before It Goes In Oven, Doing So Could Spread Germs To Nearby Food
Even though food experts have been warning people for years, the cultural norm of washing the turkey at Thanksgiving has persisted.
By brilabuskes -
Guards Facing Charges In Epstein’s Suicide Say Blame Lies With Systemic Failures In Prison System
Jeffrey Epstein's death has thrown a spotlight on the federal prison system, which has been plagued by staff shortages and chronic violence accusations for years.
By brilabuskes -
In Lawsuit, Generic Drug Group Says California’s Ban On Pay-To Delay Deals Would Hurt Competition
The FTC, however, says the deals cost U.S. consumers an estimated $3.5 billion annually. In other pharmaceutical news: anti-trust probes, a billionaire couple's work to move the House drug pricing bill through, the strategy behind Novartis' recent acquisition, brain boosting supplements, and more.
By brilabuskes -
FDA Approves New Sickle Cell Drug As Part Of Flood Of New Treatments For The Disease
“Everybody’s been waiting for this moment where the flood gate of new treatments is opening,” said Dr. Biree Andemariam, chief medical officer of the Sickle Cell Disease Association of America. But the new drug is expensive: Global Blood Therapeutics priced Oxbryta at $125,000 a year.
By brilabuskes -
PhRMA To Yank Millions In Funding From Nonprofit Geared Toward Helping Those Addicted To Opioids
PhRMA, which is responsible for 90 percent of the Addiction Policy Forum's funding, will walk back and then end its support by 2020. The forum was at the eye of previous controversy, with critics blasting the fact that most of its funding came from the drugmakers who they said were responsible for the crisis in the first place. News on the opioid epidemic comes out of Massachusetts and Ohio, as well.
By brilabuskes -
Newly Revealed Letter Shows That Border Patrol Rejected CDC’s Recommendations To Give Migrants Flu Shot
In the months after Customs and Border Protection rejected the recommendation, at least two children died after being diagnosed with the flu while in custody.
By brilabuskes -
From Equipment Failures To Jumbled Data: How CDC Disease Detectives Race To Unlock Mysteries Of Vaping Disease
CDC scientists have been scrambling to understand the mysterious vaping illness that has spread across the country in recent months. The Washington Post looks at the bumps and successes they've had along the way.
By brilabuskes -
Dems Who See Health Care As Winning Issue Increasingly Sounding Alarm Over Political Pitfalls Of ‘Medicare For All’
Warnings are being issued at all levels of the party--from union members to candidates running in swing states. “We won in Kentucky and Louisiana, barely, in part, because we won on health care. I don’t think we can afford to lose on health care," Gov. Gina Raimondo (D-R.I.) said. Meanwhile, industry opponents for "Medicare for All" are starting to go after the moderates' health plans as well. In other election news, Sen. Kamala Harris (D-Calif.) has a plan to expand mental health treatment.
By brilabuskes -
First Edition: November 26, 2019
Today's early morning highlights from the major news organizations.
By brilabuskes -
Viewpoints: Lessons On Coping With Long Waits When Emergency Care Is Needed ‘Now’; Planned Parenthood Saves Babies, Too, So Why Close Clinics?
Opinion writers weigh in on these health care topics and others.
By janicelkff